Breast Biopsy Devices Market Analysis North America,Europe,Asia,Rest of World (ROW) - US,Canada,Germany,France,China - Size and Forecast 2023-2027

Published: Dec 2022 Pages: 197 SKU: IRTNTR44126

Breast Biopsy Devices Market Forecast 2023-2027

The global breast biopsy devices market size is estimated to grow by USD 721.64 million at a CAGR of 10.95% between 2022 and 2027. The growing prevalence of breast cancer cases is increasing the demand for products and services related to breast cancer diagnosis, treatment, and management. This includes the development of new products and therapies, leading to an increasing number of products showcasing and approvals. Additionally, the increasing number of mergers and acquisitions in the market is shaping the competitive landscape and driving innovation, as companies seek to expand their product portfolios and market presence. Overall, these factors are driving growth in the market and improving outcomes for patients with breast cancer.

Cancer is a significant public health concern worldwide and a leading cause of death. Breast cancer is a common form of cancer, primarily found in women, especially those aged 65 and above. Younger women are also at risk, particularly those with a genetic predisposition or mutations in their BRCA1 and BRCA2 genes. Breast cancer screening through mammograms, ultrasounds, and MRI helps in early detection and diagnosis, leading to proper treatment. The rising incidence of breast cancer globally is driving the demand for breast biopsy procedures, boosting the growth of the market.

Market Overview:

 View the Bestselling Market Research Sample 

Market Segmentation

This market report extensively covers market segmentation by Product (biopsy needles and systems, biopsy image-guided systems, and others), End-user (hospitals, ASCs, breast cancer specialty centers and clinics, and others),  and Geography (North America, Europe, Asia, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges.

By Product 

The market share growth of the biopsy needles and systems segment will be significant during the forecast period. Needles are primarily used for collecting tissue from the suspicious areas of the breast during a biopsy. Needle biopsy is considered the gold standard procedure for breast biopsies. Core needle biopsy is a quick process that does not involve surgery. Owing to these factors, these needles are accepted by physicians for standard procedures.

Get a detailed analysis of various segments View Sample PDF 

By End-User

Hospitals are the key end-users of the market, and they majorly influence market growth. Large and medium-sized hospitals are focusing on improving their services by offering extensive oncology services, for which they are purchasing or procuring advanced devices. Most of the small hospitals have budget constraints. Hence, to reduce their expenses, such end-users avoid purchasing high-end devices, such as image-guided systems like MRI systems. To improve patient care and to offer better results, hospitals are offering interventional oncology services. Therefore, the growing number of breast cancer cases, the availability of cancer screening programs, and the increasing adoption of these devices to improve surgical efficacy will boost the market growth during the forecast period.

By Region

For more insights on the market share of various regions View PDF Sample now!

North America is estimated to contribute 39% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

The prevalence of cancer has increased in North America. Cancer is the most common disease found in the population in this region. The region has been witnessing an increase in the adoption of various advanced technologies over the past few years. The majority of the market growth in this region is driven by high technology adoption in the healthcare sector, increasing healthcare expenditure, rising prevalence of breast cancer, and growing awareness among patients about mammograms to identify breast cancer incidence.

Market Dynamics

The market is driven by the increasing focus on breast cancer screening and the need for accurate diagnosis. These devices include breast biopsy guidance systems, needle-based breast biopsy guns, breast biopsy needles, and breast biopsy forceps, used in procedures such as vacuum-assisted biopsy (VAB), fine needle aspiration biopsy (FNAB), and core needle biopsy (CNB). These devices are crucial for image-guided biopsy procedures, aiding in breast cancer detection. Factors such as reimbursements, advancements in guidance systems, and the availability of skilled surgeons and radiologists also contribute to market growth. Additionally, factors such as insulin levels, alcohol use, birth control, menopausal hormone therapy, breast implants, and the geriatric female population impact the demand for breast biopsy needle procedures and liquid biopsy methods, highlighting the importance of ongoing clinical trials and a robust healthcare infrastructure. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Market Driver

Breast biopsy devices are diverse and the top companies aim to enhance their product offerings by obtaining regulatory approvals and showcasing their products at conferences to raise awareness about breast cancer screening. This approach helps attract end-users and expand their product portfolios. This includes advancements in breast cancer detection, reimbursements, breast biopsy needle procedures, liquid biopsy techniques, participation in clinical trials, improvements in healthcare infrastructure, availability of skilled surgeons, and the use of guidance systems

Some of the products in the market that have received regulatory approval and have been showcased by companies include the following:

  • In June 2019, Fujifilm Corp. Holdings received US FDA 510(k) approval for its Biopsy Positioner (FDR -2000BPY), which is a mammographic X-ray system that provides an accurate 3D image of the location of lesions in the breast using information extracted from stereotactic pairs of 2D images and DBT. The product is used for interventional purposes, such as biopsy, pre-surgical localization, and treatment.
  • In June 2018, Cianna Medical, which is now part of Merit Medical Systems Inc. (Merit Medical Systems), showcased its product, SAVI SCOUT, at Premier Inc. Annual Breakthroughs Conference in the US. By showcasing the product at the conference in front of healthcare providers, the company was able to make them understand the value of the product in cancer screening. This product helps hospitals by improving operational efficiency.

Significant Market Trends

The demand for advanced breast biopsy devices has increased due to the rising adoption of minimally invasive procedures for breast cancer screening. Robotic platforms, surgical navigation systems, and artificial intelligence are in high demand due to their accuracy and efficiency. The use of robotics in MRI systems can localize breast abnormalities and improve procedural efficacy. companies are also developing AI-integrated solutions to help doctors analyze breast cancer and reduce human errors. For instance, Hunt Regional Healthcare's ProFound AI tool can detect malignant tissue and calcifications, reducing errors and saving time during breast biopsies.

Major Market Challenge

Physicians prefer core needle biopsy, FNA biopsy, and surgical biopsy to detect and identify breast cancer. The biopsy method used depends on the patient's situation, and guidance systems help in performing these procedures. These procedures have risks and complications. Liquid biopsy, a non-invasive process that analyzes a blood sample, is an alternative to core needle biopsy and surgical breast biopsy. It allows healthcare providers to obtain comprehensive information about the tumor and monitor disease progression without surgery. Liquid biopsy's easy acceptance, non-invasiveness, and quick results drive its adoption. The availability of alternative methods is a challenge to the adoption of traditional breast biopsy techniques and devices. Advances in liquid breast biopsy techniques are expected to increase their adoption during the forecast period.

Who are the Major Breast Biopsy Devices Market Companies?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

BIOPSYBELL Srl - The company offers breast biopsy devices and related products such as Moon Needle for the localization of breast lesions. The company manufactures medical equipment for surgeries such as assisted reproductive technology, ortho biologics, spine, and others.

The report also includes detailed analyses of the competitive landscape of the market and information about prominent and key market companies, including:

  • Advin Health Care
  • Allengers Medical Systems Ltd.
  • Argon Medical Devices Inc.
  • Becton Dickinson and Co.
  • Cook Medical LLC
  • Danaher Corp.
  • FUJIFILM Corp.
  • General Electric Co.
  • Hologic Inc.
  • IZI Medical Products
  • Merit Medical Systems Inc.
  • Metaltronica Spa
  • Planmed Oy
  • Scion Medical Technologies LLC
  • Siemens Healthineers AG
  • Suretech Medical Inc.
  • Vector Medical
  • Zamar Care
  • Carestream Health Inc.

Technavio’s report consists of a holistic analysis of the key development analysis,  development stage, key market players, their marketing strategies, and powerful innovations to help any client gain a competitive edge.  

Market Analyst Overview

The market is driven by advancements in technology, leading to the development of Vacuum-assisted biopsy (VAB) devices, Fine needle aspiration biopsy (FNAB) devices, Needle breast biopsy, Open surgical breast biopsy, and core needle biopsy (CNB) devices. These devices offer minimally invasive and precise methods for diagnosing breast abnormalities. Image guided biopsy techniques such as MRI guided breast biopsy, Ultrasound guided breast biopsy, and Mammography guided stereotactic biopsy, Minimally invasive surgeries are gaining prominence due to their accuracy. The market also includes biopsy tables, localization wires, and liquid biopsy instruments. As the demand for screening techniques grows, driven by healthcare policies and increasing breast cancer awareness, the market is expected to witness substantial growth.

The market is evolving to meet the needs of patients and healthcare providers in diagnosing breast abnormalities. Breast procedures such as biopsies are crucial for assessing cancer risk and guiding treatment decisions. Asymptomatic individuals benefit from early detection through liquid biopsies and other diagnostic tools, improving quality of life and reducing mortality rates. Surgical tools like breast surgery retractors enhance the precision of procedures like breast lumpectomy. Cancer research continues to drive innovation in the field, leading to advancements in breast cancer surgeries and the management of conditions like breast cysts. Breast ultrasound is a key imaging modality for guiding biopsies and monitoring treatment response, highlighting the importance of advanced diagnostic technologies in improving patient outcomes.

Market Scope

Report Coverage

Details

Page number

120

Base year

2022

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 10.95%

Market growth 2023-2027

USD 721.64 million

Market structure

Fragmented

YoY growth (%)

8.93

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 39%

Key consumer countries

US, Canada, Germany, France, and China

Competitive landscape

Leading companies, Competitive Strategies, Consumer engagement scope

Key companies profiled

Advin Health Care, Allengers Medical Systems Ltd., Argon Medical Devices Inc., Becton Dickinson and Co., BIOPSYBELL Srl, Cook Medical LLC, Danaher Corp., FUJIFILM Corp., General Electric Co., Hologic Inc., IZI Medical Products, Merit Medical Systems Inc., Metaltronica Spa, Planmed Oy, Scion Medical Technologies LLC, Siemens Healthineers AG, Suretech Medical Inc., Vector Medical, Zamar Care, and Carestream Health Inc.

Market dynamics

Parent market analysis, Market Forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View PDF sample

What are the Key Data Covered in this Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the market growth and forecasting of the market between 2023 and 2027
  • Precise estimation of the size of the market size and its contribution to the parent market
  • Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
  • Growth of the market industry across Europe, North America, APAC, South America, and Middle East and Africa
  • Thorough market growth analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive market analysis and report on the factors that will challenge the market research and growth of market companies

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Market Segmentation by Modality
    • Exhibit 08: Executive Summary – Chart on Incremental Growth
    • Exhibit 09: Executive Summary – Data Table on Incremental Growth
    • Exhibit 10: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 11: Parent market
    • Exhibit 12: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 13: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 14: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 15: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 17: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 18: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global breast biopsy devices market 2017 - 2021
      • Exhibit 19: Historic Market Size – Data Table on Global breast biopsy devices market 2017 - 2021 ($ million)
    • 4.2 Product Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Product Segment 2017 - 2021 ($ million)
    • 4.3 End-User Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – End-User Segment 2017 - 2021 ($ million)
    • 4.4 Modality Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Modality Segment 2017 - 2021 ($ million)
    • 4.5 Geography Segment Analysis 2017 - 2021
      • Exhibit 23: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.6 Country Segment Analysis 2017 - 2021
      • Exhibit 24: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 25: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 26: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 27: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 28: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 29: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 30: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 31: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Product

    • 6.1 Market segments
      • Exhibit 32: Chart on Product - Market share 2022-2027 (%)
      • Exhibit 33: Data Table on Product - Market share 2022-2027 (%)
    • 6.2 Comparison by Product
      • Exhibit 34: Chart on Comparison by Product
      • Exhibit 35: Data Table on Comparison by Product
    • 6.3 Biopsy needles and systems - Market size and forecast 2022-2027
      • Exhibit 36: Chart on Biopsy needles and systems - Market size and forecast 2022-2027 ($ million)
      • Exhibit 37: Data Table on Biopsy needles and systems - Market size and forecast 2022-2027 ($ million)
      • Exhibit 38: Chart on Biopsy needles and systems - Year-over-year growth 2022-2027 (%)
      • Exhibit 39: Data Table on Biopsy needles and systems - Year-over-year growth 2022-2027 (%)
    • 6.4 Biopsy image-guided systems - Market size and forecast 2022-2027
      • Exhibit 40: Chart on Biopsy image-guided systems - Market size and forecast 2022-2027 ($ million)
      • Exhibit 41: Data Table on Biopsy image-guided systems - Market size and forecast 2022-2027 ($ million)
      • Exhibit 42: Chart on Biopsy image-guided systems - Year-over-year growth 2022-2027 (%)
      • Exhibit 43: Data Table on Biopsy image-guided systems - Year-over-year growth 2022-2027 (%)
    • 6.5 Others - Market size and forecast 2022-2027
      • Exhibit 44: Chart on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 45: Data Table on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 46: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 47: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 6.6 Market opportunity by Product
      • Exhibit 48: Market opportunity by Product ($ million)

    7 Market Segmentation by End-user

    • 7.1 Market segments
      • Exhibit 49: Chart on End-user - Market share 2022-2027 (%)
      • Exhibit 50: Data Table on End-user - Market share 2022-2027 (%)
    • 7.2 Comparison by End-user
      • Exhibit 51: Chart on Comparison by End-user
      • Exhibit 52: Data Table on Comparison by End-user
    • 7.3 Hospitals - Market size and forecast 2022-2027
      • Exhibit 53: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
      • Exhibit 54: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
      • Exhibit 55: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
      • Exhibit 56: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
    • 7.4 ASCs - Market size and forecast 2022-2027
      • Exhibit 57: Chart on ASCs - Market size and forecast 2022-2027 ($ million)
      • Exhibit 58: Data Table on ASCs - Market size and forecast 2022-2027 ($ million)
      • Exhibit 59: Chart on ASCs - Year-over-year growth 2022-2027 (%)
      • Exhibit 60: Data Table on ASCs - Year-over-year growth 2022-2027 (%)
    • 7.5 Breast cancer specialty centers and clinics - Market size and forecast 2022-2027
      • Exhibit 61: Chart on Breast cancer specialty centers and clinics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 62: Data Table on Breast cancer specialty centers and clinics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 63: Chart on Breast cancer specialty centers and clinics - Year-over-year growth 2022-2027 (%)
      • Exhibit 64: Data Table on Breast cancer specialty centers and clinics - Year-over-year growth 2022-2027 (%)
    • 7.6 Others - Market size and forecast 2022-2027
      • Exhibit 65: Chart on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 66: Data Table on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 67: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 68: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 7.7 Market opportunity by End-user
      • Exhibit 69: Market opportunity by End-user ($ million)

    8 Market Segmentation by Modality

    • 8.1 Market segments
      • Exhibit 70: Chart on Modality - Market share 2022-2027 (%)
      • Exhibit 71: Data Table on Modality - Market share 2022-2027 (%)
    • 8.2 Comparison by Modality
      • Exhibit 72: Chart on Comparison by Modality
      • Exhibit 73: Data Table on Comparison by Modality
    • 8.3 Stereotactic x-ray guided breast biopsy - Market size and forecast 2022-2027
      • Exhibit 74: Chart on Stereotactic x-ray guided breast biopsy - Market size and forecast 2022-2027 ($ million)
      • Exhibit 75: Data Table on Stereotactic x-ray guided breast biopsy - Market size and forecast 2022-2027 ($ million)
      • Exhibit 76: Chart on Stereotactic x-ray guided breast biopsy - Year-over-year growth 2022-2027 (%)
      • Exhibit 77: Data Table on Stereotactic x-ray guided breast biopsy - Year-over-year growth 2022-2027 (%)
    • 8.4 Ultrasound-guided breast biopsy - Market size and forecast 2022-2027
      • Exhibit 78: Chart on Ultrasound-guided breast biopsy - Market size and forecast 2022-2027 ($ million)
      • Exhibit 79: Data Table on Ultrasound-guided breast biopsy - Market size and forecast 2022-2027 ($ million)
      • Exhibit 80: Chart on Ultrasound-guided breast biopsy - Year-over-year growth 2022-2027 (%)
      • Exhibit 81: Data Table on Ultrasound-guided breast biopsy - Year-over-year growth 2022-2027 (%)
    • 8.5 MRI-guided breast biopsy - Market size and forecast 2022-2027
      • Exhibit 82: Chart on MRI-guided breast biopsy - Market size and forecast 2022-2027 ($ million)
      • Exhibit 83: Data Table on MRI-guided breast biopsy - Market size and forecast 2022-2027 ($ million)
      • Exhibit 84: Chart on MRI-guided breast biopsy - Year-over-year growth 2022-2027 (%)
      • Exhibit 85: Data Table on MRI-guided breast biopsy - Year-over-year growth 2022-2027 (%)
    • 8.6 Market opportunity by Modality
      • Exhibit 86: Market opportunity by Modality ($ million)

    9 Customer Landscape

    • 9.1 Customer landscape overview
      • Exhibit 87: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    10 Geographic Landscape

    • 10.1 Geographic segmentation
      • Exhibit 88: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 89: Data Table on Market share by geography 2022-2027 (%)
    • 10.2 Geographic comparison
      • Exhibit 90: Chart on Geographic comparison
      • Exhibit 91: Data Table on Geographic comparison
    • 10.3 North America - Market size and forecast 2022-2027
      • Exhibit 92: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 93: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 94: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 95: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 10.4 Europe - Market size and forecast 2022-2027
      • Exhibit 96: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 97: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 98: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 99: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 10.5 Asia - Market size and forecast 2022-2027
      • Exhibit 100: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 101: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 102: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 103: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 10.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 104: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 105: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 106: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 107: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 10.7 US - Market size and forecast 2022-2027
      • Exhibit 108: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 109: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 110: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 111: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 10.8 Germany - Market size and forecast 2022-2027
      • Exhibit 112: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 113: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 114: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 115: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 10.9 France - Market size and forecast 2022-2027
      • Exhibit 116: Chart on France - Market size and forecast 2022-2027 ($ million)
      • Exhibit 117: Data Table on France - Market size and forecast 2022-2027 ($ million)
      • Exhibit 118: Chart on France - Year-over-year growth 2022-2027 (%)
      • Exhibit 119: Data Table on France - Year-over-year growth 2022-2027 (%)
    • 10.10 China - Market size and forecast 2022-2027
      • Exhibit 120: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 121: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 122: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 123: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 10.11 Canada - Market size and forecast 2022-2027
      • Exhibit 124: Chart on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 125: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 126: Chart on Canada - Year-over-year growth 2022-2027 (%)
      • Exhibit 127: Data Table on Canada - Year-over-year growth 2022-2027 (%)
    • 10.12 Market opportunity by geography
      • Exhibit 128: Market opportunity by geography ($ million)

    11 Drivers, Challenges, and Trends

    • 11.1 Market drivers
      • 11.2 Market challenges
        • 11.3 Impact of drivers and challenges
          • Exhibit 129: Impact of drivers and challenges in 2022 and 2027
        • 11.4 Market trends

          12 Vendor Landscape

          • 12.1 Overview
            • 12.2 Vendor landscape
              • Exhibit 130: Overview on Criticality of inputs and Factors of differentiation
            • 12.3 Landscape disruption
              • Exhibit 131: Overview on factors of disruption
            • 12.4 Industry risks
              • Exhibit 132: Impact of key risks on business

            13 Vendor Analysis

            • 13.1 Vendors covered
              • Exhibit 133: Vendors covered
            • 13.2 Market positioning of vendors
              • Exhibit 134: Matrix on vendor position and classification
            • 13.3 Argon Medical Devices Inc.
              • Exhibit 135: Argon Medical Devices Inc. - Overview
              • Exhibit 136: Argon Medical Devices Inc. - Product / Service
              • Exhibit 137: Argon Medical Devices Inc. - Key news
              • Exhibit 138: Argon Medical Devices Inc. - Key offerings
            • 13.4 Becton Dickinson and Co.
              • Exhibit 139: Becton Dickinson and Co. - Overview
              • Exhibit 140: Becton Dickinson and Co. - Business segments
              • Exhibit 141: Becton Dickinson and Co. - Key news
              • Exhibit 142: Becton Dickinson and Co. - Key offerings
              • Exhibit 143: Becton Dickinson and Co. - Segment focus
            • 13.5 BIOPSYBELL Srl
              • Exhibit 144: BIOPSYBELL Srl - Overview
              • Exhibit 145: BIOPSYBELL Srl - Product / Service
              • Exhibit 146: BIOPSYBELL Srl - Key offerings
            • 13.6 Cook Medical LLC
              • Exhibit 147: Cook Medical LLC - Overview
              • Exhibit 148: Cook Medical LLC - Product / Service
              • Exhibit 149: Cook Medical LLC - Key offerings
            • 13.7 Danaher Corp.
              • Exhibit 150: Danaher Corp. - Overview
              • Exhibit 151: Danaher Corp. - Business segments
              • Exhibit 152: Danaher Corp. - Key news
              • Exhibit 153: Danaher Corp. - Key offerings
              • Exhibit 154: Danaher Corp. - Segment focus
            • 13.8 FUJIFILM Corp.
              • Exhibit 155: FUJIFILM Corp. - Overview
              • Exhibit 156: FUJIFILM Corp. - Business segments
              • Exhibit 157: FUJIFILM Corp. - Key news
              • Exhibit 158: FUJIFILM Corp. - Key offerings
              • Exhibit 159: FUJIFILM Corp. - Segment focus
            • 13.9 General Electric Co.
              • Exhibit 160: General Electric Co. - Overview
              • Exhibit 161: General Electric Co. - Business segments
              • Exhibit 162: General Electric Co. - Key news
              • Exhibit 163: General Electric Co. - Key offerings
              • Exhibit 164: General Electric Co. - Segment focus
            • 13.10 Hologic Inc.
              • Exhibit 165: Hologic Inc. - Overview
              • Exhibit 166: Hologic Inc. - Business segments
              • Exhibit 167: Hologic Inc. - Key news
              • Exhibit 168: Hologic Inc. - Key offerings
              • Exhibit 169: Hologic Inc. - Segment focus
            • 13.11 IZI Medical Products
              • Exhibit 170: IZI Medical Products - Overview
              • Exhibit 171: IZI Medical Products - Product / Service
              • Exhibit 172: IZI Medical Products - Key offerings
            • 13.12 Merit Medical Systems Inc.
              • Exhibit 173: Merit Medical Systems Inc. - Overview
              • Exhibit 174: Merit Medical Systems Inc. - Business segments
              • Exhibit 175: Merit Medical Systems Inc. - Key offerings
              • Exhibit 176: Merit Medical Systems Inc. - Segment focus
            • 13.13 Metaltronica Spa
              • Exhibit 177: Metaltronica Spa - Overview
              • Exhibit 178: Metaltronica Spa - Product / Service
              • Exhibit 179: Metaltronica Spa - Key offerings
            • 13.14 Planmed Oy
              • Exhibit 180: Planmed Oy - Overview
              • Exhibit 181: Planmed Oy - Product / Service
              • Exhibit 182: Planmed Oy - Key offerings
            • 13.15 Scion Medical Technologies LLC
              • Exhibit 183: Scion Medical Technologies LLC - Overview
              • Exhibit 184: Scion Medical Technologies LLC - Product / Service
              • Exhibit 185: Scion Medical Technologies LLC - Key offerings
            • 13.16 Siemens Healthineers AG
              • Exhibit 186: Siemens Healthineers AG - Overview
              • Exhibit 187: Siemens Healthineers AG - Business segments
              • Exhibit 188: Siemens Healthineers AG - Key news
              • Exhibit 189: Siemens Healthineers AG - Key offerings
              • Exhibit 190: Siemens Healthineers AG - Segment focus
            • 13.17 Zamar Care
              • Exhibit 191: Zamar Care - Overview
              • Exhibit 192: Zamar Care - Product / Service
              • Exhibit 193: Zamar Care - Key offerings

            14 Appendix

            • 14.1 Scope of the report
              • 14.2 Inclusions and exclusions checklist
                • Exhibit 194: Inclusions checklist
                • Exhibit 195: Exclusions checklist
              • 14.3 Currency conversion rates for US$
                • Exhibit 196: Currency conversion rates for US$
              • 14.4 Research methodology
                • Exhibit 197: Research methodology
                • Exhibit 198: Validation techniques employed for market sizing
                • Exhibit 199: Information sources
              • 14.5 List of abbreviations
                • Exhibit 200: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              breast biopsy devices market market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis